Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries with a low prevalence of tuberculosis. A statement of the International Union Against Tuberculosis and Lung Disease.
D001500:BCG Vaccine / Q000009:adverse effects; D002675:Child, Preschool; D006801:Humans; D017589:Immunization Programs; D007223:Infant; D007231:Infant, Newborn; D015995:Prevalence; D014376:Tuberculosis / Q000453:epidemiology / Q000517:prevention & control*; D014390:Tuberculosis, Meningeal / Q000453:epidemiology; D014397:Tuberculosis, Pulmonary / Q000453:epidemiology
D001500:BCG Vaccine